Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionMork Capital Management, LLC
Latest Disclosed Ownership3,350 shares
Latest Disclosed Value $ 1,178,698
Mork Capital Management, LLC reports 13.44% decrease in ownership of AMGN / Amgen Inc.

On May 15, 2026 - Mork Capital Management, LLC filed a 13F-HR form disclosing ownership of 3,350 shares of Amgen Inc. (CH:AMGN) valued at $1,178,698 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,870 shares of Amgen Inc.. This represents a change in shares of -13.44% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMGEN COM 031162100 3,350 -520 -13.44 1,179 -6.95 0.8368
2026-02-17 2025-12-31 13F AMGEN COM 031162100 3,870 0 0.00 1,267 15.93 0.7733
2025-11-14 2025-09-30 13F AMGEN COM 031162100 3,870 0 0.00 1,092 1.11 0.7525
2025-08-14 2025-06-30 13F AMGEN COM 031162100 3,870 0 0.00 1,081 -10.37 0.7883
2025-05-15 2025-03-31 13F AMGEN COM 031162100 3,870 0 0.00 1,206 19.54 0.9443
2025-02-14 2024-12-31 13F AMGEN COM 031162100 3,870 400 11.53 1,009 -9.84 0.6638
2024-11-14 2024-09-30 13F AMGEN COM 031162100 3,470 0 0.00 1,118 3.14 0.8011
2024-08-14 2024-06-30 13F AMGEN COM 031162100 3,470 0 0.00 1,084 9.94 0.8498
2024-05-14 2024-03-31 13F AMGEN COM 031162100 3,470 0 0.00 987 -1.30 0.7439
2024-02-14 2023-12-31 13F AMGEN COM 031162100 3,470 260 8.10 999 15.89 0.6146
2023-11-13 2023-09-30 13F AMGEN COM 031162100 3,210 0 0.00 863 21.07 0.6735
2023-08-11 2023-06-30 13F AMGEN COM 031162100 3,210 0 0.00 713 -8.25 0.5471
2023-05-12 2023-03-31 13F AMGEN COM 031162100 3,210 -1,290 -28.67 776 -34.29 0.6309
2023-02-14 2022-12-31 13F AMGEN COM 031162100 4,500 0 0.00 1,182 16.47 0.9065
2022-11-14 2022-09-30 13F AMGEN COM 031162100 4,500 0 0.00 1,014 -7.40 0.9958
2022-08-15 2022-06-30 13F AMGEN COM 031162100 4,500 0 0.00 1,095 0.64 1.0026
2022-05-13 2022-03-31 13F AMGEN COM 031162100 4,500 0 0.00 1,088 7.51 0.9812
2022-02-15 2021-12-31 13F AMGEN COM 031162100 4,500 100 2.27 1,012 8.12 0.6855
2021-11-15 2021-09-30 13F AMGEN COM 031162100 4,400 0 0.00 936 -12.77 0.7982
2021-08-16 2021-06-30 13F AMGEN COM 031162100 4,400 0 0.00 1,073 -2.01 0.7745
2021-05-14 2021-03-31 13F AMGEN COM 031162100 4,400 0 0.00 1,095 8.20 0.8339
2021-02-17 2020-12-31 13F AMGEN COM 031162100 4,400 4,400 1,012 0.7419
2020-05-15 2020-03-31 13F AMGEN COM 031162100 0 -4,000 -100.00 0 -100.00
2020-02-12 2019-12-31 13F AMGEN COM 031162100 4,000 0 0.00 964 24.55 0.6896
2019-11-14 2019-09-30 13F AMGEN COM 031162100 4,000 0 0.00 774 5.02 0.7097
2019-08-12 2019-06-30 13F AMGEN COM 031162100 4,000 0 0.00 737 -3.03 0.6826
2019-05-13 2019-03-31 13F AMGEN COM 031162100 4,000 -1,800 -31.03 760 -32.68 0.7065
2019-02-13 2018-12-31 13F AMGEN COM 031162100 5,800 0 0.00 1,129 -6.07 1.0532
2018-11-07 2018-09-30 13F AMGEN COM 031162100 5,800 0 0.00 1,202 12.23 0.9675
2018-08-08 2018-06-30 13F AMGEN COM 031162100 5,800 0 0.00 1,071 8.29 0.9460
2018-05-15 2018-03-31 13F AMGEN COM 031162100 5,800 0 0.00 989 -1.98 0.9478
2018-02-02 2017-12-31 13F AMGEN COM 031162100 5,800 0 0.00 1,009 -6.66 0.6737
2017-11-09 2017-09-30 13F AMGEN COMM 031162100 5,800 0 0.00 1,081 8.21 0.8758
2017-08-09 2017-06-30 13F AMGEN COMM 031162100 5,800 0 0.00 999 4.94 0.8597
2017-05-08 2017-03-31 13F AMGEN COMM 031162100 5,800 -600 -9.38 952 1.71 0.8475
2017-02-10 2016-12-31 13F AMGEN COMM 031162100 6,400 0 0.00 936 -12.36 0.6578
2016-11-09 2016-09-30 13F AMGEN COMM 031162100 6,400 0 0.00 1,068 9.65 1.0189
2016-08-12 2016-06-30 13F AMGEN COMM 031162100 6,400 0 0.00 974 1.46 0.9686
2016-05-13 2016-03-31 13F AMGEN COMM 031162100 6,400 0 0.00 960 -7.60 0.9353
2016-01-27 2015-12-31 13F AMGEN COMM 031162100 6,400 0 0.00 1,039 17.40 0.9967
2015-11-10 2015-09-30 13F AMGEN COMM 031162100 6,400 0 0.00 885 -9.97 1.0419
2015-08-07 2015-06-30 13F AMGEN COMM 031162100 6,400 0 0.00 983 -3.91 1.1579
2015-05-07 2015-03-31 13F AMGEN COMM 031162100 6,400 6,400 1,023 1.1844
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.